2022-2028 is the forecast period in the market report.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the global cell culture media market. In addition, complete analysis of changes on the global cell culture media market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 is an infectious disease caused by the recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan, China in December 2019, COVID-19 escalated from a regional crisis to a global pandemic within weeks. After the World Health Organization (WHO) officially declared the COVID-19 outbreak a pandemic, a mix of established pharmaceutical and biopharmaceutical companies and small start-ups have emerged to develop treatments and vaccines that target the infection caused by the new target coronavirus.
In the pharmaceutical industry, cell culture has become an important part of vaccine production. Cell culture technology has been used to produce vaccines against rotavirus, poliomyelitis, smallpox, hepatitis, rubella and varicella. Cell-based influenza vaccines have also been approved in the United States and many European countries.
Previously, vaccines were made by growing and harvesting viruses from chicken eggs, which was time-consuming. On the other hand, cell culture-based vaccine production is a much more efficient method. Advantages over traditional manufacturing methods include shorter lead times and the ability to produce vaccines in larger quantities as needed. Additionally, cell culture-based vaccines can be stored for a longer period of time. These factors are expected to drive growth of the market during the estimated time period.
The market is expected to have new opportunity with the technological advancements & ongoing R&D activities involved in the production of cell culture media. It is expected to provide ample of new growth opportunities for the market during the forecast period. Regenerative medicine is a new field of medicine that promises therapies to replace tissue/organ systems in the human body. Regenerative medicine uses cells, biomaterials and molecules to repair body structures that have been damaged by injury or disease. The Wake Forest Institute for Regenerative Medicine (USA) is studying replacement tissue and organ growth techniques for nearly 30 parts of the body, including skin, bladder and liver. Cell therapies and regenerative medicine hold enormous potential to improve the health aspects of many patients with chronic diseases. The imminent and growing need for new therapies to solve debilitating health problems is driving manufacturers to develop innovative cell culture systems. This is another factor which is expected to create new opportunities for growth in the upcoming years.
The cell biology research requires the use of animals and humans as animal and human cells are used in gene therapy studies involving gene recombination and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic tests of drugs that can be harmful to animals and humans. Furthermore, stem cell research studies use human embryos for clinical applications that often lead to the destruction of human embryos. To control these activities, ethics authorities in several countries around the world have put in place strict regulations. Authorities such as the Human Tissue Authority (HTA), the Human Fertilization and Embryology Authority (HFEA), the Medicines and Health Products Regulatory Agency (MHRA) and the Central Ethics Committee for Research on stem cells (SEZs), among others, have introduced strict rules for cell biology research. These ethical concerns and limitations to the use of cells for research severely limit cell biological research in several countries around the world. This, in turn, should limit the demand for cell culture products, including cell culture media and is another factor which is restraining the market growth.
Given the strong presence of large players in the market, it is difficult for small players and new entrants to compete in this market. Since large investments are required for R&D and the introduction of innovative products, it is difficult for small companies to stay in business and compete with established companies with large R&D budgets. Also, lack of skilled professionals and ethical & scientific concerns associated with culture media is expected to be major challenge for the market growth over the forecast the period.
The report provides in-depth analysis of global cell culture media market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. With increasing demand for various cell culture media in various applications has led the increasing demand for market and is expected to witness the growth at a specific CAGR from 2021-2028.
The global Cell Culture Media market comprises of different market segment like type, form, application, end users and geography.
By type, the cell culture media market includes the key segments of
The serum-free media segment is expected to dominate the market over the forecast period. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth and productivity, better control of physiological reactivity, and reduced risk of contamination with adventitious serum active ingredients in cell culture.
By form, the cell culture media market is segmented into
The liquid media segment is anticipated to maintain its dominance over the estimated time period. An increasing number of producers of biological and biosimilars, both downstream and upstream, are switching from premixed powders to liquid media due to factors such as rapid growth of mycobacteria and high isolation rates. In addition, it eliminates some process steps and also reduces the risk of exposure to hazardous substances and makes production and development more flexible and simple than powdered fluids. In addition, the ready-to-use liquid media also eliminates the need for mixing containers, scales and the installation of a water for injections (WFI) circuit required to mix the powder media. The growth of the segment is also driven by the strategic activities of manufacturers.
CELL CULTURE MEDIA MARKET BY APPLICATION
The cancer research segment is expected to witness the fastest growth owing to the increase in cancer research activities and skyrocketing increase in cancer cases. The need to precisely create the in vivo cellular conditions to study the mechanism of cancer has created a demand for custom-defined media that is accelerating the market growth. Due to increasing technological advancements in molecular biology and the cultivation of human and other mammalian cells, cell cultures are also used in genetic engineering. In vitro techniques have improved the ability to introduce functional genes into a variety of cells used to treat various genetic diseases such as diabetes, infertility, cancer and hereditary diseases (cystic fibrosis and haemophilia).
The cell culture media market has major end users like
The biotechnology & pharmaceutical industry segment is expected to witness the highest growth over the estimated time period. The growing use of single-use technologies, the growing number of regulatory approvals for culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are driving the growth of this segment. The expansion of current biopharmaceutical manufacturing capabilities is driving demand for cell culture products. Furthermore, the increase in clinical trials over the evaluation period will present profitable opportunities and is expected to contribute a healthy growth in the market over the forecast period.
The global Cell Culture Media market is studied for the following region
North America region is expected to dominate the market over the forecast period. This large share can be attributed to the growth of the pharmaceutical and biotech industries, the increase in approvals for cell culture-based vaccines, and the increased incidence of diseases such as cancer combined with investment and funding in cell-based research.
The competitive landscape analysis of cell culture media market is majorly focused on expanding the global growth of cell culture media with new product innovation, business expansion, increasing presence of range of manufacturers operating in cell culture media has led the growing demand for the market. Besides, the market offers range of products in different application to fulfil the required demand of consumers which is further contributing healthy growth in the market.
The key players studied in market are
October 2021: Seqirus had received U.S. FDA approval for FLUCELVAX QUADRIVALENT, the first and only cell-based influenza vaccine in the U.S.
July 2021: Sartorius AG had announced that the company had acquired Xell AG which specialized in cell culture thus expanding its capabilities for manufacturing dry powder and liquid media.
|Market Sizing for Year:||2021-2028|
|Market Segment studied:|
|Market Players and its Competitors:|
Merck KGaA (Germany)
Thermo Fisher Scientific Inc. (US)
Danaher Corporation (US)
STEMCELL Technologies Inc. (Canada)
Sartorius AG (Germany)
Cell Applications, Inc. (US)
FUJIFILM Irvine Scientific, Inc. (US)
Lonza Group AG (Switzerland)
HiMedia Laboratories Pvt. Ltd. (India)
STEMCELL Technologies Inc. (Canada)
Athena Environmental Sciences, Inc (US)
Caisson Laboratories Inc. (US)
PromoCell GmbH (Germany)Cell Biologics, Inc. (US)
FREQUENTLY ASKED QUESTIONS
What would be forecast period in the market report?
2022-2028 is the forecast period in the market report.
Which is the leading application segment for Cell Culture Media market?
Biotechnology & Pharmaceutical Industry has accounted the major market share, and is expected to witness the growth at highest pace during the forecast period.
Which region is gaining majority of market share during the forecast period (2022-2028)?
North America is expected to gain major market share during the forecast period (2022-2028).